Figure 1.

Mean frequency of somatic mutations in cancer genes in endometrioid and serous ECs. The data were derived for genes that have been evaluated in at least 40 tumors of each subtype: FGFR2,^52,100,101 KRAS,^{38,52,53,57,63,77,78,80,87,88,90,92,100,102,105} PIK3CA,^52,57 PIK3R1,^52,58 PPP2R1A,^133–135 PTEN,^{52,53,56,57,59,60,62,72,102,196–198} TP53.^{52,60,80,92,122,128,129,131,196}